Preeclampsia during pregnancy may lead to hypertension,DM within 5 years

Published On 2018-03-30 13:35 GMT   |   Update On 2018-03-30 13:35 GMT

Preeclampsia is a dangerous condition in which a pregnant woman develops hypertension and protein in the urine and it occurs in up to 7 percent of all pregnancies. The symptoms typically resolve within six weeks after delivery, contributing to a perception among care providers and patients that further medical monitoring is unnecessary.Dr.Karlee Hoffman at Allegheny Health Network and colleagues have found in a study that Women diagnosed with preeclampsia during pregnancy were significantly more likely to develop high blood pressure, diabetes or high cholesterol within five years compared with women who did not have it. The study was presented at the American College of Cardiology's 67th Annual Scientific Session.


The study is among the first to track outcomes following a diagnosis of preeclampsia and bolsters the evidence that it contributes to cardiovascular risk factors that were not present before pregnancy. The study, which followed women for five years, also found few women received medical follow-up aimed at preventing cardiovascular problems after preeclampsia.


"As providers, we're missing the boat if we're not adequately following up with these patients on their cardiovascular risk factors," said Karlee Hoffman, DO, a cardiology fellow at Allegheny Health Network and the study's lead author. "Women are highly motivated to take care of themselves when they are pregnant and after they deliver their babies, so it's a great time to educate them on long-term cardiovascular risks and potentially intervene with aggressive lifestyle modification."


Researchers analyzed the health records of more than 650 women treated at Allegheny Health Network between 2009 and 2015. Half had been diagnosed with preeclampsia and half were women of a similar age and racial makeup who were controls. Five years of follow-up health information was available for just over 250 of the women diagnosed with preeclampsia.


Around the time of their delivery, those with preeclampsia had a higher rate of obesity, preterm delivery, babies with low birth weight and post-delivery complications. Over the following five years, those with preeclampsia were more likely to develop high blood pressure (which occurred in 32.8 percent of women with preeclampsia and 0.3 percent of controls), new-onset diabetes (which occurred in 21 percent of women with preeclampsia and zero among controls) and high cholesterol (which occurred in 3 percent of women with preeclampsia and zero among controls).


"The incidence of preeclampsia is relatively high and so is the risk of having a subsequent diagnosis of these cardiovascular risk factors," Hoffman said. "We need to work with our obstetrics and gynecology colleagues to capture these patients and refer them to a primary care doctor or a cardiologist for a more rigorous follow-up to help prevent future cardiovascular disease."


"The results also showed that African-American women, women who were older at the time of their pregnancy and women with a prior history of high blood pressure or diabetes faced an especially elevated risk of high blood pressure following preeclampsia, suggesting women with these risk factors should receive even more rigorous medical follow-up," Hoffman said.


Although the exact causes are unknown, it is thought that oxidative stress, which results from having too much of the unstable form of oxygen in the body, could play a role in the cardiovascular effects seen after preeclampsia. Oxidative stress has been linked with the physiological changes that contribute to coronary artery disease. To further elucidate the connections between the two researchers are planning a study that will use echocardiography and noninvasive pulse wave velocity.


Article Source : with inputs American College of Cardiology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News